Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypes
- PMID: 40604231
- PMCID: PMC12223171
- DOI: 10.1038/s41598-025-98344-x
Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypes
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a high-mortality cancer characterized by its aggressive, treatment-resistant phenotype and a complex tumour microenvironment (TME) featuring significant hypoxia. Bulk transcriptomic analysis has identified the "classical" and "basal-like" transcriptional subtypes which have prognostic value; however, it is not well-established how microenvironmental heterogeneity contributes to these transcriptional signatures. Here, we exploited the TRACER platform to perform single cell transcriptome analysis of organoids at specific spatial locations to explore the effect of oxygen and other cell-generated microenvironmental gradients on organoid heterogeneity. We found that the microenvironmental gradients present in TRACER significantly impact the distribution of organoid transcriptional phenotypes and the enrichment of gene sets linked to cancer progression and treatment resistance. More significantly, we found that microenvironmental gradients, predominantly oxygen, drive changes in the expression of classical and basal-like transcriptional subtype gene signatures. This work suggests that hypoxia contributes to determining transcriptional subtypes in PDAC tumour cells independent of additional cells in the TME and broadly highlights the importance of considering microenvironmental gradients such as oxygen in organoid-based studies.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Hypoxia-induced MIR31HG expression promotes partial EMT and basal-like phenotype in pancreatic ductal adenocarcinoma based on data mining and experimental analyses.J Transl Med. 2025 Mar 10;23(1):305. doi: 10.1186/s12967-025-06292-x. J Transl Med. 2025. PMID: 40065368 Free PMC article.
-
HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma.Curr Gene Ther. 2025;25(1):62-71. doi: 10.2174/1566523223666230720101531. Curr Gene Ther. 2025. PMID: 37475556
-
Establishment of a Prognostic Model for Pancreatic Cancer Based on Hypoxia-Related Genes.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241288687. doi: 10.1177/15330338241288687. Technol Cancer Res Treat. 2024. PMID: 39431298 Free PMC article.
-
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice.J Transl Med. 2025 Jul 4;23(1):744. doi: 10.1186/s12967-025-06778-8. J Transl Med. 2025. PMID: 40616159 Free PMC article. Review.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
References
-
- American Cancer Society. Cancer Facts & Figs. 2022. (2022). https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-...
-
- Chan-Seng-Yue, M. et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat. Genet.52, 231–240 (2020). - PubMed
-
- Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature531, 47–52 (2016). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical